exchange fell shortly after the open on Tuesday in a broad decline led in part by the Bank of Nova Scotia, which reported a lower-than-expected quarterly profit, and a sell off in ValeantPharmaceuticalsInternational Inc shares.

TORONTO, March 2 (Reuters) - Canada's main stock index rose on Monday as a jump in ValeantPharmaceuticalsInternational Inc helped offset weakness in the energy sector after the price of Brent crude oil dropped.

The $14.5 billion acquisition of Salix Pharmaceuticals SLXP brings Valeant Pharmaceuticals VRX into an entirely new therapeutic area, but the deal is very compelling financially. Management expects the deal to increase 2016

NEW YORK (Reuters) - Canada's ValeantPharmaceuticalsInternational Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.

NEW YORK (Reuters) - Canada's ValeantPharmaceuticalsInternational Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.

NEW YORK, Feb 22 (Reuters) - ValeantPharmaceuticalsInternational Inc. agreed to acquire Salix Pharmaceuticals Ltd. for $158.00 per share, or a total enterprise value of $14.5 billion, the two companies said on Sunday.